ApprovalTrail

Approval · Notice of Compliance 4667 · 1996

NUTROPIN: Notice of Compliance 4667

Issued July 24, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4667
Date
July 24, 1996
Company
Hoffmann-La Roche LimitedMississauga, Ontario, Canada
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Growth hormone

Products in this notice

BrandDINStatus today
NUTROPIN02216183Cancelled Post Market
NUTROPIN02216191Cancelled Post Market

Medicinal ingredients